145 related articles for article (PubMed ID: 25940156)
1. A rapid, reproducible, noninvasive predictor of liver graft survival.
Zarrinpar A; Lee C; Noguchi E; Yersiz H; Agopian VG; Kaldas FM; Farmer DG; Busuttil RW
J Surg Res; 2015 Jul; 197(1):183-90. PubMed ID: 25940156
[TBL] [Abstract][Full Text] [Related]
2. Donor Indocyanine Green Clearance Test Predicts Graft Quality and Early Graft Prognosis After Liver Transplantation.
Tang Y; Han M; Chen M; Wang X; Ji F; Zhao Q; Zhang Z; Ju W; Wang D; Guo Z; He X
Dig Dis Sci; 2017 Nov; 62(11):3212-3220. PubMed ID: 28932926
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Plasma Disappearance Rate Indocyanine Green Clearance as a Predictor of Liver Graft Rejection in Donor Brain Death.
Asencio JM; Cortese S; López Baena JA; Olmedilla L; Pérez Peña JM; Salcedo MM; Matilla A; Martín L; Martínez C; Orue-Echebarria MI; Lozano P
Transplant Proc; 2020 Jun; 52(5):1472-1476. PubMed ID: 32217011
[TBL] [Abstract][Full Text] [Related]
4. Impact of deceased organ donor demographics and critical care end points on liver transplantation and graft survival rates.
Bloom MB; Raza S; Bhakta A; Ewing T; Patel M; Ley EJ; Margulies DR; Salim A; Malinoski D
J Am Coll Surg; 2015 Jan; 220(1):38-47. PubMed ID: 25458800
[TBL] [Abstract][Full Text] [Related]
5. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
Escorsell À; Mas A; Fernández J; García-Valdecasas JC
Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
[TBL] [Abstract][Full Text] [Related]
6. Association between the donor to recipient ICG-PDR variation rate and the functional recovery of the graft after orthotopic liver transplantation: A case series.
Cherchi V; Vetrugno L; Terrosu G; Zanini V; Ventin M; Pravisani R; Tumminelli F; Brollo PP; Boscolo E; Peressutti R; Lorenzin D; Bove T; Risaliti A; Baccarani U
PLoS One; 2021; 16(8):e0256786. PubMed ID: 34449820
[TBL] [Abstract][Full Text] [Related]
7. Donor Age-Based Analysis of Liver Transplantation Outcomes: Short- and Long-Term Outcomes Are Similar Regardless of Donor Age.
Chapman WC; Vachharajani N; Collins KM; Garonzik-Wang J; Park Y; Wellen JR; Lin Y; Shenoy S; Lowell JA; Doyle MB
J Am Coll Surg; 2015 Jul; 221(1):59-69. PubMed ID: 25872684
[TBL] [Abstract][Full Text] [Related]
8. Donor Risk Index Has an Impact in Intraoperative Measure of Hepatic Artery Flow and in Clearance of Indocyanine Green: An Observational Cohort Study.
Lozano P; Orue-Echebarria MI; Asencio JM; Sharma H; Lisbona CJ; Olmedilla L; Pérez Peña JM; Salcedo MM; Skaro A; Velasco E; Colón A; Díaz-Zorita B; Rodríguez L; Ferreiroa J; López-Baena JÁ
Transplant Proc; 2019; 51(1):50-55. PubMed ID: 30655145
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Indocyanine Green Plasma Disappearance Rate in Liver Donors and Recipients: A Prospective Observational Study.
Cortese S; López Baena JÁ; Pérez Peña JM; Matilla AM; Olmedilla L; Morales Taboada Á; Fernández Vázquez ML; Fernández Martínez M; Asencio JM
Transplant Proc; 2022 Nov; 54(9):2545-2548. PubMed ID: 36270855
[TBL] [Abstract][Full Text] [Related]
10. Plasma disappearance rate of indocyanine green: a tool to evaluate early graft outcome after liver transplantation.
Levesque E; Saliba F; Benhamida S; Ichaï P; Azoulay D; Adam R; Castaing D; Samuel D
Liver Transpl; 2009 Oct; 15(10):1358-64. PubMed ID: 19790157
[TBL] [Abstract][Full Text] [Related]
11. Impact of reversible cardiac arrest in the brain-dead organ donor on the outcome of adult liver transplantation.
Levesque E; Hoti E; Khalfallah M; Salloum C; Ricca L; Vibert E; Azoulay D
Liver Transpl; 2011 Oct; 17(10):1159-66. PubMed ID: 21744468
[TBL] [Abstract][Full Text] [Related]
12. Impact of Donor Pre-Procurement Cardiac Arrest (PPCA) on Clinical Outcomes in Liver Transplantation.
Mangus RS; Schroering JR; Fridell JA; Kubal CA
Ann Transplant; 2018 Nov; 23():808-814. PubMed ID: 30455411
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study.
Angelico M; Nardi A; Marianelli T; Caccamo L; Romagnoli R; Tisone G; Pinna AD; Avolio AW; Fagiuoli S; Burra P; Strazzabosco M; Costa AN;
J Hepatol; 2013 Apr; 58(4):715-23. PubMed ID: 23201239
[TBL] [Abstract][Full Text] [Related]
14. Early Measurement of Indocyanine Green Clearance Accurately Predicts Short-Term Outcomes After Liver Transplantation.
Olmedilla L; Lisbona CJ; Pérez-Peña JM; López-Baena JA; Garutti I; Salcedo M; Sanz J; Tisner M; Asencio JM; Fernández-Quero L; Bañares R
Transplantation; 2016 Mar; 100(3):613-20. PubMed ID: 26569066
[TBL] [Abstract][Full Text] [Related]
15. Risk factors and criteria predicting early graft loss after adult-to-adult living donor liver transplantation.
Du Z; Wei Y; Chen K; Chen X; Zhang Z; Li H; Ma Y; Li B
J Surg Res; 2014 Apr; 187(2):673-82. PubMed ID: 24275573
[TBL] [Abstract][Full Text] [Related]
16. Internal and external validation of indocyanine green plasma disappearance rate to discard liver grafts before procurement.
Cortese S; Plua K; Perez-Alonso AJ; Hontoria MS; Pacheco D; Carroll NZ; Gómez MÁB; Peña JMP; Taboada ÁGM; Martínez MF; Kakauridze SH; Matilla AM; Baena JÁL; Asencio JM
Ann Hepatobiliary Pancreat Surg; 2024 Jun; ():. PubMed ID: 38898570
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive indocyanine green plasma disappearance rate predicts early complications, graft failure or death after liver transplantation.
Schneider L; Spiegel M; Latanowicz S; Weigand MA; Schmidt J; Werner J; Stremmel W; Eisenbach C
Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):362-8. PubMed ID: 21813383
[TBL] [Abstract][Full Text] [Related]
18. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
19. Indocyanine green elimination test in orthotopic liver recipients.
Tsubono T; Todo S; Jabbour N; Mizoe A; Warty V; Demetris AJ; Starzl TE
Hepatology; 1996 Nov; 24(5):1165-71. PubMed ID: 8903393
[TBL] [Abstract][Full Text] [Related]
20. How do transplant surgeons accomplish optimal portal venous flow during living-donor liver transplantation? Noninvasive measurement of indocyanine green elimination rate.
Hori T; Ogura Y; Yagi S; Iida T; Taniguchi K; El Moghazy WM; Hedaya MS; Segawa H; Ogawa K; Kogure T; Uemoto S
Surg Innov; 2014 Feb; 21(1):43-51. PubMed ID: 23703675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
